ArticleBMC infectious diseases2025
New scoring system combining WHO ordinal scale and MASCC score in predicting mortality of COVID-19 patients with malignancy and neutropenia: a retrospective cohort study.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCOVID-19 has become a common infectious disease globally and predicting prognosis of hospitalized COVID-19 patients is important, especially for patients with risk factors like febrile neutropenia. Our research aimed to analyze prognostic factors of COVID-19 patients with neutropenia and develop effective scoring system to predict the mortality in these patients.
methodsData of COVID-19 patients with neutropenia who presented to the emergency department were extracted from electronic health records across multiple hospitals between April 2021 and September 2022. The primary outcome was in-hospital mortality. Various scoring systems, including the Multinational Association for Supportive Care in Cancer risk index (MASCC) score, World Health Organization (WHO) ordinal scale, and the combination of these two scoring systems, were used and compared for prediction of prognosis.
resultsA total of 304 adult COVID-19 in-hospital patients with neutropenia were included into the study. Higher rates of intubation, oxygen use, and ICU admission were observed in the non-survival group. The MASCC score, the WHO ordinal scale and the combined scoring system showed predictive ability for in-hospital mortality, and the combined scoring system had the best predictive power.
conclusionAlthough MASCC score and WHO ordinal score were useful to predict the prognosis of COVID-19 patients with neutropenia, the new system combining MASCC score and WHO ordinal scale had the best performance in predicting the mortality. Intubation, body temperature, and creatine level were the most significant prognostic factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.